This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...

IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...